Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience

PURPOSE: Outcomes for early-stage breast cancer have improved. First-generation adjuvant chemotherapy trials reported a 0.27% 8-year cumulative incidence of myelodysplastic syndrome/acute myelogenous leukemia. Incomplete ascertainment and follow-up may have underestimated subsequent risk of treatmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Wolff, Antonio C., Blackford, Amanda L., Visvanathan, Kala, Rugo, Hope S., Moy, Beverly, Goldstein, Lori J., Stockerl-Goldstein, Keith, Neumayer, Leigh, Langbaum, Terry S., Theriault, Richard L., Hughes, Melissa E., Weeks, Jane C., Karp, Judith E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4302215/
https://ncbi.nlm.nih.gov/pubmed/25534386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.54.6119
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados